Dilated cardiomyopathy differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
| Line 21: | Line 21: | ||
|- | |- | ||
|Amphetamine/Cocaine Cardiomyopathy | |Amphetamine/Cocaine Cardiomyopathy | ||
| | |||
| | |||
| | |||
|- | |||
|Arrhythmogenic right ventricular | |||
cardiomyopathy (ARVC/D) | |||
| | | | ||
| | | | ||
| Line 41: | Line 47: | ||
|- | |- | ||
|Hypertrophic Cardiomyopathy | |Hypertrophic Cardiomyopathy | ||
| | |||
| | |||
| | |||
|- | |||
|Left ventricular noncompaction | |||
| | | | ||
| | | | ||
Revision as of 01:28, 9 December 2019
|
Dilated cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dilated cardiomyopathy differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Dilated cardiomyopathy differential diagnosis |
|
Risk calculators and risk factors for Dilated cardiomyopathy differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction
Differentiating Beriberi from other Diseases
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction
| Disorders | Etiology | Clinical Presentation | Laboratory Findings |
|---|---|---|---|
| Acute Pericarditis | |||
| Amphetamine/Cocaine Cardiomyopathy | |||
| Arrhythmogenic right ventricular
cardiomyopathy (ARVC/D) |
|||
| Beriberi | |||
| Cardiac Temponade | |||
| Thyrotoxicosis | |||
| Hypertrophic Cardiomyopathy | |||
| Left ventricular noncompaction | |||
| Myocarditis | |||
| Restrictive Cardiomyopathy |
References